Para Snow Sports classification: Part 1 Research and collaboration to ensure fair competition
Jul 04, 2025 - Learn about all aspects of the classification process across…
Beko Recognised as One of TIME Magazine’s Most Sustainable Companies in the World 2025
Holding the top spot in its industry, the company makes its second…
Runwal Raaya Hosts an Immersive Evening with Tao Art Gallery
Runwal Raaya transforms into a canvas for contemporary Indian artBollywood's Neha Dhupia…
NYSE Content advisory: Pre-Market update + Trump tariffs to resume Aug. 1
NEW YORK, July 7, 2025 /PRNewswire/ -- The New York Stock Exchange…
DXC Technology Appoints Professional Services Industry Veteran Ramnath Venkataraman as President of Consulting & Engineering Services
ASHBURN, Va., July 7, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading…
beGalileo Deepens School Impact with Navneet, Expands Inclusive Learning Through Endeavor ELS Partnership
BENGALURU, India, July 7, 2025 /PRNewswire/ -- beGalileo, the Bangalore-based EdTech company…
Hisense Makes Home Smarter to Help Fans ‘Own the Moment’ During FIFA Club World Cup 2025
QINGDAO, China, July 7, 2025 /PRNewswire/ -- Hisense, a leading brand in…
Glow & Lovely Launches ‘Apni Roshni Baahar La’, a Nationwide Movement to Empower Women to Lead, Influence and Shine
Introduces 'The Glow Up Academy' with the ambition to nurture one digital…
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
Exclusive agreement includes over $70 million in upfront and milestone payments to…
